Citation: | QIN Jingjing, PENG Kaiyue, WANG Yue, HAN Qingfeng. Analysis of factors related to microalbuminuria in community populations[J]. Chinese Journal of General Practice, 2023, 21(10): 1710-1712. doi: 10.16766/j.cnki.issn.1674-4152.003207 |
[1] |
ROSENSTOCK J, PERKOVIC V, ALEXANDER J H, et al. Rationale, design, and baseline characteristics of the CARMELINA: a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk[J]. Cardiovasc Diabetol, 2018, 17(1): 39. doi: 10.1186/s12933-018-0682-3
|
[2] |
SHIKATA K, KODERA R, UTSUNOMIYA K, et al. Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: the Japan diabetes complication and its prevention prospective study 5[J]. J Diabetes Investig, 2020, 11(2): 325-332. doi: 10.1111/jdi.13116
|
[3] |
PRASAD R M, BALI A, TIKARIA R. Microalbuminuria[M/OL]//StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing, 2023.
|
[4] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202112018.htm
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)[J]. Chinese Journal Of Diabetes Mellitus, 2021, 13(4): 315-409. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202112018.htm
|
[5] |
KIBRIA G M A, CRISPEN R. Prevalence and trends of chronic kidney disease and its risk factors among US adults: an analysis of NHANES 2003-18[J]. Prev Med Rep, 2020, 20(1): 101193. DOI: 10.1016/j.pmedr.2020.101193.
|
[6] |
徐建伟, 刘敏, 王思琦, 等. 中国6省18~75岁人群微量白蛋白尿检出情况及影响因素[J]. 中华疾病控制杂志, 2021, 25(10): 1164-1168. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202110009.htm
XU J W, LIU M, WANG S Q, et al. Prevalence and influencing factors of microalbuminuria among general population aged from 18 to 75 years old in 6 provinces of China[J]. Chinese Journal of Disease Control & Prevention, 2021, 25(10): 1164-1168. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202110009.htm
|
[7] |
DUAN J Y, DUAN G C, WANG C J, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey[J]. BMC Nephrol, 2020, 21(1): 115. doi: 10.1186/s12882-020-01761-5
|
[8] |
DUAN J Y, WANG C J, LIU D W, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey[J]. Sci Rep, 2019, 9(1): 10408. DOI: 10.1038/s41598-019-46857-7.
|
[9] |
张竞, 阿地拉·阿里木, 郭艳英, 等. 乌鲁木齐市天山区维吾尔族女性围绝经期和绝经后期代谢综合征现况及危险因素分析[J]. 中华全科医学, 2023, 21(1): 73-76, 126. doi: 10.16766/j.cnki.issn.1674-4152.002815
ZHANG J, ADILA ALIMU, GUO Y Y, et al. Prevalence and risk factors of metabolic syndrome among pre-menopausal and post-menopausal women of Uygur in Tianshan District of Urumqi[J]. Chinese Journal of General Practice, 2023, 21(1): 73-76, 126. doi: 10.16766/j.cnki.issn.1674-4152.002815
|
[10] |
RAIKOU V D, GAVRⅡL S. Metabolic syndrome and chronic renal disease[J]. Diseases, 2018, 6(1): 12. doi: 10.3390/diseases6010012
|
[11] |
BAGASRAWALA S I, SHETH H, SHAH H, et al. Metabolic syndrome rather than obesity alone is more significant for kidney disease[J]. Obes Surg, 2019, 29(11): 3478-3483. doi: 10.1007/s11695-019-04011-2
|
[12] |
BOVOLINI A, GARCIA J, ANDRADE M A, et al. Metabolic syndrome pathophysiology and predisposing factors[J]. Int J Sports Med, 2021, 42(3): 199-214. doi: 10.1055/a-1263-0898
|
[13] |
GAEINI Z, BAHADORAN Z, MIRMIRAN P, et al. Spot urinary microalbumin concentration, metabolic syndrome and type 2 diabetes: Tehran lipid and glucose study[J]. BMC Endocr Disord, 2022, 22(1): 59. doi: 10.1186/s12902-022-00976-x
|
[14] |
SAADI M M, ROY M N, HAQUE R, et al. Association of microalbuminuria with metabolic syndrome: a cross-sectional study in Bangladesh[J]. BMC Endocr Disord, 2020, 20(1): 153.
|
[15] |
XU J W, MA J X, CHEN X R, et al. Association of microalbuminuria and high-normal 24-hour urinary albumin excretion with metabolic syndrome and its components in the general Chinese population: cross-sectional study[J]. BMJ Open, 2019, 9(11): e031443. DOI: 10.1136/bmjopen-2019-031443.
|
[16] |
陶旭轲, 潘宁宁, 刘敏, 等. 微量白蛋白尿与代谢综合征及其组分的关联性研究[J]. 中华疾病控制杂志, 2023, 27(4): 448-452. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202304013.htm
TAO X K, PAN N N, LIU M, et al. Association of microalbuminuria with metabolic syndrome and its components[J]. Chinese Journal Of Disease Control & Prevention, 2023, 27(4): 448-452. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202304013.htm
|